Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aldevron provides GMP-compliant manufacturing of plasmid DNA and other biologics used in commercialized products as well as clinical-stage therapies. It has supported the world’s first personalized mRNA-based CRISPR gene editing drug product for a rare metabolic disorder[2]. The company’s facilities have passed regulatory inspections from FDA CBER and German authorities with no major findings[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aldevron.